Stelliam Investment Management LP Has Upped Range Res (RRC) Position; Shorts at TAXUS CARDIUM PHARMA (CRXM) Raised By 31.58%

June 19, 2017 - By Maria Brooks

TAXUS CARDIUM PHARMA (OTCMKTS:CRXM) had an increase of 31.58% in short interest. CRXM’s SI was 10,000 shares in June as released by FINRA. Its up 31.58% from 7,600 shares previously. With 14,400 avg volume, 1 days are for TAXUS CARDIUM PHARMA (OTCMKTS:CRXM)’s short sellers to cover CRXM’s short positions. It is 0.00% or $0 reaching $0.17 per share. It is down 0.00% since June 19, 2016 and is . It has underperformed by 16.70% the S&P500.

Stelliam Investment Management Lp increased Range Res Corp (RRC) stake by 49.64% reported in 2016Q4 SEC filing. Stelliam Investment Management Lp acquired 1.56M shares as Range Res Corp (RRC)’s stock declined 18.29%. The Stelliam Investment Management Lp holds 4.70M shares with $161.32 million value, up from 3.14 million last quarter. Range Res Corp now has $5.75B valuation. The stock declined 1.78% or $0.41 reaching $22.97 on the news. About 3.66M shares traded. Range Resources Corp. (NYSE:RRC) has declined 36.05% since June 19, 2016 and is downtrending. It has underperformed by 52.75% the S&P500.

Taxus Cardium Pharmaceuticals Group Inc. is engaged in managing a medical technologies portfolio of equity and potential royalty-driven investments. The company has market cap of $2.43 million. The Company’s portfolio includes Angionetics, Inc. ; Activation Therapeutics, Inc. (Activation Therapeutics); LifeAgain Insurance Solutions, Inc. (LifeAgain), and a minority investment in Healthy Brands Collective. It currently has negative earnings. Angionetics is its subsidiary focused on late-stage clinical development and commercialization of Generx, which is an angiogenic gene therapy product candidate designed for medical revascularization for treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease.

Investors sentiment decreased to 1.2 in Q4 2016. Its down 0.81, from 2.01 in 2016Q3. It is negative, as 57 investors sold RRC shares while 127 reduced holdings. 60 funds opened positions while 160 raised stakes. 216.83 million shares or 6.80% more from 203.02 million shares in 2016Q3 were reported. Weitz Investment owns 892,669 shares or 1.22% of their US portfolio. Ingalls And Snyder Limited Liability Company holds 0.03% or 14,394 shares. Glenmede Trust Na reported 4,850 shares or 0% of all its holdings. Bluecrest Cap Mgmt, Guernsey-based fund reported 11,040 shares. Loomis Sayles & LP has 0% invested in Range Resources Corp. (NYSE:RRC). Brigade Cap Mgmt Lp has invested 0.42% in Range Resources Corp. (NYSE:RRC). The New York-based American Intll Grp Incorporated has invested 0.01% in Range Resources Corp. (NYSE:RRC). Moreover, Balyasny Asset Management Ltd Liability has 0.05% invested in Range Resources Corp. (NYSE:RRC) for 259,992 shares. Us National Bank De holds 0.01% or 42,627 shares in its portfolio. Northwestern Mutual Wealth holds 0% of its portfolio in Range Resources Corp. (NYSE:RRC) for 4,078 shares. Ironwood Finance Ltd Company has 0% invested in Range Resources Corp. (NYSE:RRC) for 99 shares. 45,830 were accumulated by Dynamic Capital Management Ltd. Stoneridge Ptnrs Limited Liability Co, Pennsylvania-based fund reported 78,956 shares. Gulf Int Bankshares (Uk) Ltd reported 56,776 shares. Broadview Advsrs Limited Liability has invested 2.1% of its portfolio in Range Resources Corp. (NYSE:RRC).

Stelliam Investment Management Lp decreased Barrett Bill Corp (NYSE:BBG) stake by 1.13 million shares to 5.36M valued at $37.48M in 2016Q4. It also reduced Amag Pharmaceuticals Inc (Prn) stake by 15.25 million shares and now owns 11.50M shares. Anadarko Pete Corp (NYSE:APC) was reduced too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: